Saturday, August 12, 2017

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients by GINA KOLATA


By GINA KOLATA

Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.

Published: August 11, 2017 at 08:00PM

from NYT Health http://ift.tt/2fBCrz7
via IFTTT




from WordPress http://ift.tt/2uQPgYh
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)